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ABSTRACT
O bjective: There is no widely accepted standard definition for Ventilator Associated
Pneumonia (VAP). The reliability of the current definitions in use remains controversial.
Our objective was to assess the reliability of six commonly used VAP definitions: The
Loose, The Rigorous, The Modified Clinical Pulmonary Infection Score (CPIS), The
Canadian Critical Care Trials Group (CCCTG), The International Sepsis Forum Consensus
(ISFC) and The Center for Disease Control and Prevention (CDC).
Design: We examined the electronic health records of all the consecutively admitted
adult patients at our institution who received invasive mechanical ventilation (IMV)
for ≥ 48 hours, from January 2006 through December 2006.Patients were excluded
if they developed pneumonia within the first 48 hours or if they had a tracheostomy
before IMV. Two expert intensivists independently reviewed the following data for each
patient: indications and duration of IMV, vital signs, oxygen requirements, the frequency
of respiratory suctioning, amount, color and consistency of secretion, ventilator settings,
leukocyte count, microbiologic and radiographic data. Interreviewer reliability in
diagnosing VAP independently were compared using Cohen’s-Kappa statistics.
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Results : A total of 115 patients met the initial inclusion criteria of which 47 patients were
excluded (40 had pneumonia on presentation, 6 developed pneumonia within 48 hours
and 1 had a tracheostomy on admission). The inter-reviewer agreement Kappa for the
Loose, the Rigorous, CPIS, CCCTG, ISFC and CDC definitions for VAP were 0.22, 0.49, 0.33,
0.41, 0.38 and 0.68 respectively.
Conclusion: The CDC definition of VAP proved to be statistically more reliable than other
tested definitions of VAP, as demonstrated by the lowest interrater variability between
two independent reviewers.
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INTRODUCTION
Ventilator-associated pneumonia (VAP) is the most
common nosocomial infection in mechanically
ventilated intensive care unit (ICU) patients.1 The
data collected by National Healthcare Safety Network
(NHSN) from 2006 and 2008 revealed an incidence
of VAP that ranged from approximately 3 per
MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

1000 ventilator days in medical/surgical teaching
ICUs to almost 11 per 1000 ventilator days in burn
units.2 Using the same definition, subsequent data
from 2011 demonstrated VAP rates of 1.1 per 1000
ventilator days in medical/surgical teaching ICUs and
approximately 5 per 1000 ventilator days in burn
units.3 Various institutions have traditionally used
the CDC definition to identify VAPs for reporting
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nosocomial infections to the NHSN, however, several
other definitions have been used for both clinical and
research applications. There exists no consensus for
a gold standard definition for VAP and the reliability
of currently used definitions remains in question.4-7
There are six definitions that are commonly used for
VAP: the Loose,8 the Rigorous,8 the Modified Clinical
Pulmonary Infection Score (CPIS),8,9 the Canadian
Critical Care Trials Group (CCCTG),10 the International
Sepsis Forum Consensus (ISFC)11 and the Center for
Disease Control and Prevention (CDC).12 Despite the
abundance of literature on VAP, there is a paucity of
studies that compare the difference in VAP incidence
using different clinical definitions of VAP in the same
patient population.7,13

excluded. Two expert intensivists (Reviewers A
and B) independently screened the EMRs of all
the included patients to make a diagnosis of VAP
(figure 1). The reviewers discussed the different
definitions at the beginning of the study to assure
mutual understanding of the definitions. The
reviewers screened patients’ records for changes
in temperature, change in oxygen requirements,
change in WBC count, and sputum cultures. If
any change was detected, the reviewers would
subject the case to the various definitions of VAP
to determine which definitions applied. During
the review process there was no direct discussion
between the reviewers pertinent to any case in the
study.

Therefore, we conducted a population-based study
to test the interrater variability of six commonly used
VAP definitions; the Loose, the Rigorous, CPIS, CCCTG,
ISFC and CDC.

In addition to the clinical, microbiological,
radiographic data, and laboratory reports, patients’
demographics, baseline conditions, comorbidities,
severity of illness (Acute Physiology and Chronic
Health Evaluation [APACHE III] score, organ

METHODS
We conducted a retrospective electronic medical
record (EMR) chart review of all the adult patients (≥
18 years) from Olmsted County who were admitted
to the Intensive Care
Units (ICU) at our center,
and required invasive
mechanical ventilation
(IMV) for > 48 hours, from
January 1, 2006 through
December 31, 2006.
The Institutional Review
Board (IRB) approved
the study (#10-006656).
After receiving the IRB
approval, we identified
patients who gave consent
for the use of their EMR
for research, and met the
inclusion criteria. Patients
who had pneumonia on
presentation, developed
pneumonia within 48
hours from admission
or had a tracheostomy
upon admission were
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FIGURE 1. The flowchart showing the method for
diagnosing ventilator associated pneumonia.
Footnote: ICU=intensive care unit, MV=mechanical
ventilation; VAP= ventilator associated pneumonia
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dysfunction (Sequential Organ Failure Assessment
[SOFA] score, reasons for MV, intubation type,
infection severity (sepsis, severe sepsis or septic
shock),14 modified CPIS score,15 documented
witnessed aspiration, prescription of appropriate
initial antimicrobial treatment, and compliance
with Institute of Health Care Improvement
ventilator bundle were abstracted from the EMR.
Other important variables that were abstracted
included date of admission, admission diagnosis,
date and location of intubation, indication for IMV,
duration of IMV, vital signs, oxygen requirements,
frequency of respiratory suctioning, amount, color
and consistency of secretion, ventilator settings,
leukocytes, potential sources of infection, date of
extubation and date of dismissal or expiration and
nutritional status. Whenever the constellation of
clinical, laboratory, microbiologic and radiographic
data suggested the development of pneumonia
the reviewers independently would apply the six
definitions to determine whether or not a given
patient met the criteria for one or more definition.
A patient identified as having VAP by any definition
is considered as a positive case of VAP. The detailed
explanation about the six VAP definitions is given in
the online supplement.

to estimate the inter-reviewer variability for each
one of the six definitions for VAP between the two
reviewers.16 A kappa value of <0.2 was considered to
reflect poor inter-reviewer agreement, 0.21-0.40 was
considered fair, 0.41-0.60 was considered moderate,
0.61-0.80 was considered good and >0.80 was
considered excellent.16 For this study, we defined
“reliability” as the VAP definition with the lowest level
of interrater variability between two independent
observers. It is important to know that reliability
does not imply “accuracy” of VAP diagnosis (whether
a patient has or does not have VAP) – only that
observers using a particular definition arrived at the
same diagnostic conclusion. All of the analyses were
performed using JMP 9.0 software (SAS Institute;
Cary, NC).
RESULTS
During the study, 115 patients met the initial
inclusion criteria. After thorough independent
revision by both reviewers, the reviewers excluded
47 patients (40 had pneumonia on presentation, 6
developed pneumonia within 48 hours and 1 had a
tracheostomy on admission) (Figure 2).
FIGURE 2. The interrater variability of different ventilator
associated pneumonia definitions.

STATISTICAL ANALYSIS
The categorical data was
summarized as counts
and percentage, whereas,
continuous data was
summarized as median
(interquartile range [IQR]).
Student’s-t test and MannWhitney U test were used
to compare the continuous
variables with normal
distribution and skewed
distribution, respectively,
whereas Chi-square and
Fisher’s exact test were used
to compare the categorical
variables, depending on the
size of the variable in the
contingency table. Cohen’s
kappa statistics were used
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The table shows the differences in baseline
characteristics, causes for mechanical ventilation,
comorbidities, and outcomes between the patients
with VAP (all the possible cases identified by both the
authors) and without VAP. There was no difference
in the baseline characteristics and severity of illness
between the VAP and non-VAP patients. Most of
the patients with VAP were admitted in the surgical
ICU (81%) as compared to the patients without
VAP (55%), p=0.06. The most common antecedent
documented conditions in VAP patients were coma
(43%), postoperative state (19%), cardiogenic
pulmonary edema (10%) and acute respiratory
distress syndrome (ARDS) (10%) (Table).
VAP patients were re-intubated more often than
non-VAP patients (29% vs. 6%, respectively) p=0.02.
There was no difference in the mortality at hospital
discharge among the VAP and non-VAP patients
TABLE: Differences in baseline characteristics, causes, comorbidities, and outcomes between ventilator associated
pneumonia (VAP) and non-VAP patientsa

(p=0.51), however, VAP patients were mechanically
ventilated for a longer duration (p=0.01) and
had longer length of stay in the ICU (p <0.01) as
compared to non-VAP patients.
For cases that were suspected to have developed
VAP, reviewer A determined that 10, 3, 6, 13, 14 and
8 cases met the Loose, the Rigorous, CPIS, CCCTG,
ISFC and CDC Definition, respectively. Whereas, the
reviewer B determined that 5, 1, 5, 5, 5 and 5 met
The Loose, The Rigorous, CPIS, CCCTG, ISFC and
CDC Definition, respectively. The kappa value for
the Loose, the Rigorous, CPIS, CCCTG, ISFC and CDC
definitions between the two reviewers was 0.22,
0.49, 0.33, 0.41, 0.38 and 0.68 respectively (Figure 2).
DISCUSSION
We evaluated the interrater/reviewer variability of six
common definitions used to identify VAP in the ICU.
We observed large inter-reviewer variability when
diagnosing VAP from medical record review. Out of
the six definitions of VAP, only the CDC definition
had good interrater variability between the two
reviewers. The Rigorous and CCCTG definitions
were moderately reliable, whereas, the Loose, CPIS
and ISFC definitions were only fairly reliable in
diagnosing VAP. To the best of our knowledge, this is
the first study that measured the interrater variability
of VAP definitions.
VAP definitions rely on integrating clinical findings,
radiographic and microbiologic data to establish
the diagnosis. The clinical findings can be in part
subjective, and hence, vulnerable to variability in
the way they are documented and interpreted.
Additionally, chest radiographic changes can be due
to pathological processes other than, but resembling
pneumonia ranging from lung contusion in trauma
patients to pulmonary edema and pleural effusions
in heart failure patients. The matter is complicated
further by the fact that some of the radiographic
changes can persist for weeks, potentially masking
new processes. Previous studies support the finding
that interpretation of chest radiographs can vary
between clinicians.17,18 Treating physicians and
radiologists may also interpret chest radiographs
differently.18,19 Furthermore, microbiologic data can
be difficult to interpret, as mechanically ventilated
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patients’ airways invariably become colonized
with hospital flora. ICU patients commonly receive
prophylactic, empiric or therapeutic antimicrobials,
which can result in change in patients’ flora and
select out for resistant opportunistic and pathogenic
bacteria. They can also suppress bacterial growth
and decrease the yield of cultures. All of these issues
have to be taken in consideration when processing
microbiologic information in this patient population.
Some authorities have proposed that respiratory
cultures obtained invasively via bronchoscopy should
be the gold standard in making the diagnosis of
VAP. This notion is impractical to apply in clinical
practice. The invasive nature of the procedure, the
time it takes to perform, and the cost of procedure,
are certainly barriers to its utility in investigating VAP.
Furthermore, the level of training and expertise of the
reviewer can affect the processing of data necessary
to diagnose VAP. In one study looking at these two
variables, inter-observer agreement was moderate at
best when applying the CDC definition.20 Relying on
objective data to diagnose VAP may be a better way
to standardize reviewers and institutions reporting
for epidemiologic purposes, however, from a clinical
perspective it may be difficult, due to the need for
assessing various parameters to diagnose VAP.
Several governing bodies are interested in
institutional VAP rates. The mandate for public
reporting is on the horizon. The way Centers for
Medicare and Medicaid Service will consider VAP
rates in the reimbursement process remains unclear.
In addition, it remains unclear if these governing
bodies will use epidemiologic criteria, i.e. NHSN
reports, or administrative data, i.e. ICD-9 coding,
to compare different institutions in quality of care
performance measures. The major concern with
the use of administrative databases to measure VAP
incidence rates is the underreporting of VAP cases in
these databases,19 which falsely lowers the incidence
of VAP in the community. For this reason, the CDC
introduced new possible/probable VAP definitions
that address various events that could affect patients
while on mechanical ventilation.21 The new definition
is rather a group of definitions that are meant to
distinguish ventilator associated events that are
not necessarily infectious in nature from those that
are infectious in nature. Those that are infectious in
nature are then further classified into possible and
probable VAP. In the most simple way to understand
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the new definitions: for a patient to be considered
to have a possible or probable VAP, he or she would
have to have at least two days of invasive mechanical
ventilation with stable fraction of inspired oxygen
(FiO2) and positive end-expiratory pressure (PEEP)
for at least two days. He or she would have to then
develop a change in either FiO2 or PEEP (>20%
increase or >3 cm H2O respectively) and the change
be sustained for at least two days, and accompanied
by evidence of inflammatory response (leukocytosis
and/or fever) or clinical suspicion of infectious
process for which antibiotics are initiated and
continued along with purulent respiratory secretions
and/or positive respiratory secretions cultures for a
bacterial pathogen. The new definition focuses on
changes in oxygenation as a trigger to investigate
a possible VAP. It aims to distinguish between
infectious and non-infectious complications of
mechanical ventilation, and acknowledges the fact
that VAP diagnosis is not always clear-cut and can
be possible or probable. The new definitions are
expected to be more objective and less susceptible
to individual variation in interpretation, but will need
to be studied further. At the time we conducted our
study, the new CDC definitions were not available.
Our study has both strengths and weaknesses.
Major strengths are 1) the population-based nature
of the study, designed specifically to study the
interrater variability of the VAP definitions eliminates
the referral and sampling biases seen in the
observational studies; 2) we used a comprehensive
approach to diagnose the VAP cases and used a
standardized operating protocol throughout the
study, which enhanced the quality of our study.
This study also has limitations. Only two observers
participated and there was a wide variability
between each observer collectively using any
definition of VAP. It is retrospective which may lend
to confounding and unmeasured bias. To account
for these biases we used quality measures like a
standardized protocol for data gathering, diagnosis
of the VAP and data extraction. Although the study
was conducted at a single center, which raises
some concerns regarding the generalizability of
the results, Mayo Clinic is the only center providing
critical care services in the Olmsted County.22
Furthermore, findings from the Olmsted County
population have shown to be generalizable to the
Upper Midwest population and provide invaluable
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information regarding various diseases, which are
consistent with the national data.23,24
CONCLUSION
The CDC definition of VAP proved to be statistically
more reliable than other tested definitions of VAP
as demonstrated by the lowest interrater variability
between two independent reviewers.
SUPPLEMENT
The six definitions used in this study:
1. Loose definition: chest x-ray infiltrate (unilobar,
unilateral, or bilateral) with 2 of the following 3
findings: temperature, >38°C or <35.5°C; white
blood cell count, >10,000/μL or <4000/μL; or
purulent respiratory secretions.
2. Rigorous definition: chest x-ray infiltrate
(unilobar, unilateral, or bilateral) with all of the
following 3 findings: temperature, >38°C or
<35.5°C; white blood cell count, >10,000/μL or
<4000/μL; or purulent respiratory secretions.
3. The modified clinical pulmonary infection score
(CPIS) ≥6.
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4. The Canadian Critical Care Trials Group
classification
A. Definite bacterial pneumonia: at least one
of the following three criteria was fulfilled:
1. Positive result of pleural fluid culture
2. Rapid cavitation of the lung infiltrate as
determined by computed tomography or
3. Histopathologic demonstration of
pneumonia (consolidation with intense
polymorphonuclear leukocyte accumulation
in bronchioles and adjacent alveoli involving
several adjacent low-power microscopic,
with or without tissue necrosis) during
biopsy or autopsy.
B. Probable bacterial pneumonia: if none
of the above criteria were met yet patient
had cultures of specimens obtained using a
bronchoalveolar lavage which grew at least one
organism in significant concentration (>104 cfu/
ml).
C. Possible pneumonia: if none of the above
criteria were met yet patient’s chest radiograph,
sputum culture, temperature, white blood cell
count and clinical course were consistent with
pneumonia.
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D. No pneumonia: if in the opinion of the
study investigator, the patient’s course was not
compatible with pneumonia.
5. The International Sepsis Forum Consensus
definition
1. Microbiologically confirmed: if fulfilled one
of the following criteria
a. The patient must have a new or
progressive radiographic infiltrate,
along with a high clinical suspicion of
pneumonia (or a CPIS of ≥6, using a Gram
stain of a lower respiratory tract sample)
plus a definite cause established by the
recovery of a probable etiologic agent
from a) an uncontaminated specimen
(blood, pleural fluid, transtracheal
aspirate, or transthoracic aspirate);
b. The recovery from respiratory
secretions of a likely pathogen that does
not colonize the upper airways (e.g.,
Mycobacterium tuberculosis, Legionella
species, influenza virus, or Pneumocystis
jiroveci (carinii);
c.
Recovery of a likely/possible
respiratory pathogen in high
concentrations using quantitative cultures
of a lower respiratory tract sample
(endotracheal aspirate, BAL, or protected
specimen brush)
d. Positive serology.
2. Probable: The patient must have a new or
progressive radiographic infiltrate along with
a high clinical suspicion of pneumonia (or
a CPIS of ≥6, using a Gram stain of a lower
respiratory tract sample) plus detection (by
staining or culture) of a likely pulmonary
pathogen in respiratory secretions
(expectorated sputum, endotracheal or
bronchoscopic aspirate, or quantitatively
cultured bronchoscopic BAL fluid or brush
catheter specimen), but in concentrations
below the diagnostic threshold, or the
presence of a negative lower respiratory
tract culture if collected within 72 hours after
starting a new antibiotic regimen.
3. Possible: Abnormal chest radiograph of
uncertain cause, in a patient with a low or
moderate clinical suspicion of pneumonia,
but with microbiological or serological
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evidence of definite or probable pneumonia
(as defined above).
6. The Center for Disease Control and Prevention
(CDC).
Clinical diagnosis of VAP was defined as the presence
of new or progressive and persistent infiltrates, or
consolidation, or cavitations on the chest radiograph,
and at least 1 of the following: fever >38°C with no
other recognized cause, leukocytosis (≥12.0 × 109/L)
or leukopenia (<4.0 × 109/L), or altered mental status
with no other cause in ≥70 years old; and at least
2 of the following: new onset of purulent sputum
or change in character of sputum or increased
respiratory secretions or increased suctioning
requirements, new onset or worsening cough or
dyspnea or tachypnea, rales or bronchial breath
sound, worsening gas.
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